Literature DB >> 34907915

The Journal of Clinical Investigation in the time of COVID-19.

Arturo Casadevall, Sarah Jackson, Gregg L Semenza, Gordon F Tomaselli, Rexford S Ahima.   

Abstract

In this editorial, we describe the experience of the JCI editors during the COVID-19 pandemic. Our goal is to share how we operated during the pandemic, recount how the JCI contributed to the response, highlight some of the major papers we published on SARS-CoV-2 and COVID-19, and impart our insights in the hope that these are helpful to journal editors that may need to deal with similar types of crises in the future.

Entities:  

Mesh：

Year:  2021        PMID： 34907915      PMCID： PMC8670845          DOI： 10.1172/JCI156409

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  31 in total

Review 1.  A history of the American Society for Clinical Investigation.

Authors:  Joel D Howell
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

2.  A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.

Authors:  Max R O'Donnell; Beatriz Grinsztejn; Matthew J Cummings; Jessica E Justman; Matthew R Lamb; Christina M Eckhardt; Neena M Philip; Ying Kuen Cheung; Vinay Gupta; Esau João; Jose Henrique Pilotto; Maria Pia Diniz; Sandra Wagner Cardoso; Darryl Abrams; Kartik N Rajagopalan; Sarah E Borden; Allison Wolf; Leon Claude Sidi; Alexandre Vizzoni; Valdilea G Veloso; Zachary C Bitan; Dawn E Scotto; Benjamin J Meyer; Samuel D Jacobson; Alex Kantor; Nischay Mishra; Lokendra V Chauhan; Elizabeth F Stone; Flavia Dei Zotti; Francesca La Carpia; Krystalyn E Hudson; Stephen A Ferrara; Joseph Schwartz; Brie A Stotler; Wen-Hsuan W Lin; Sandeep N Wontakal; Beth Shaz; Thomas Briese; Eldad A Hod; Steven L Spitalnik; Andrew Eisenberger; Walter I Lipkin
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

3.  Mechanistic science.

Authors:  Arturo Casadevall; Ferric C Fang
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

4.  One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19.

Authors:  Riccardo Levi; Elena Azzolini; Chiara Pozzi; Leonardo Ubaldi; Michele Lagioia; Alberto Mantovani; Maria Rescigno
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

5.  The convalescent sera option for containing COVID-19.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

6.  Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic.

Authors:  Rexford S Ahima; Sarah Jackson; Arturo Casadevall; Gregg L Semenza; Gordon Tomaselli; Kathleen L Collins; Andrew P Lieberman; Donna M Martin; Pavan Reddy
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

7.  SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.

Authors:  Arne Sattler; Stefan Angermair; Helena Stockmann; Katrin Moira Heim; Dmytro Khadzhynov; Sascha Treskatsch; Fabian Halleck; Martin E Kreis; Katja Kotsch
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

8.  A perspective on potential antibody-dependent enhancement of SARS-CoV-2.

Authors:  Ann M Arvin; Katja Fink; Michael A Schmid; Andrea Cathcart; Roberto Spreafico; Colin Havenar-Daughton; Antonio Lanzavecchia; Davide Corti; Herbert W Virgin
Journal:  Nature       Date:  2020-07-13       Impact factor: 49.962

9.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

10.  Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.

Authors:  Arbor G Dykema; Boyang Zhang; Bezawit A Woldemeskel; Caroline C Garliss; Laurene S Cheung; Dilshad Choudhury; Jiajia Zhang; Luis Aparicio; Sadhana Bom; Rufiaat Rashid; Justina X Caushi; Emily Han-Chung Hsiue; Katherine Cascino; Elizabeth A Thompson; Abena K Kwaa; Dipika Singh; Sampriti Thapa; Alvaro A Ordonez; Andrew Pekosz; Franco R D'Alessio; Jonathan D Powell; Srinivasan Yegnasubramanian; Shibin Zhou; Drew M Pardoll; Hongkai Ji; Andrea L Cox; Joel N Blankson; Kellie N Smith
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808
View more
  1 in total

1.  Ayekoo! - Well done!

Authors:  Rexford S Ahima
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.